analyst
PA
NASDAQ · PACB
Pacific Biosciences of California, Inc.
Healthcare · Medical - Devices
$1.96
Down-$0.01 (-0.51%)
Updated Nov 15, 2026, 10:11 PM
SID Score
4.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 652.12M
- P/E ratio
- -1.29
- Dividend yield
- 0.00%
- 52-week range
- $1.07 – $3.44
- Volume
- 7.02M
- Avg. volume
- 9M
Price performance · PACB
PACB price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Nov 13, 2026
PACB closed at $1.96 after 20 trading sessions, up 6.52% for the selected period.
- Last close
- $1.96
- Period change
- +6.52%
- Period low
- $1.84
- Period high
- $2.90
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | $1.99 | $2.00 | $1.84 | $1.96 | 7.02M |
| Nov 12, 2026 | $1.99 | $2.06 | $1.80 | $1.97 | 10.34M |
| Nov 11, 2026 | $2.29 | $2.3486 | $2.07 | $2.09 | 10.69M |
| Nov 10, 2026 | $2.31 | $2.345 | $2.12 | $2.24 | 8.89M |
| Nov 9, 2026 | $2.23 | $2.43 | $2.16 | $2.36 | 11.84M |
| Nov 6, 2026 | $2.43 | $2.54 | $2.24 | $2.255 | 9.56M |
| Nov 5, 2026 | $2.24 | $2.69 | $2.23 | $2.43 | 20.58M |
| Nov 4, 2026 | $2.53 | $2.70 | $2.48 | $2.55 | 20.97M |
| Nov 3, 2026 | $2.41 | $2.5799 | $2.4001 | $2.44 | 6.26M |
| Nov 2, 2026 | $2.68 | $2.7194 | $2.31 | $2.345 | 9.1M |
| Oct 30, 2026 | $2.75 | $2.82 | $2.4101 | $2.605 | 13.74M |
| Oct 29, 2026 | $2.775 | $2.96 | $2.74 | $2.90 | 11.97M |
| Oct 28, 2026 | $2.45 | $3.065 | $2.44 | $2.83 | 35.05M |
| Oct 27, 2026 | $2.26 | $2.525 | $2.23 | $2.45 | 18.69M |
| Oct 26, 2026 | $2.12 | $2.305 | $2.08 | $2.25 | 9.57M |
| Oct 23, 2026 | $2.02 | $2.13 | $1.97 | $2.11 | 5.72M |
| Oct 22, 2026 | $2.13 | $2.21 | $2.05 | $2.06 | 9.18M |
| Oct 21, 2026 | $1.965 | $2.1891 | $1.92 | $2.14 | 13.5M |
| Oct 20, 2026 | $1.815 | $2.06 | $1.7601 | $1.96 | 10.36M |
| Oct 19, 2026 | $1.78 | $1.86 | $1.74 | $1.84 | 6.04M |
Latest PACB news
The latest Smart Investors Daily articles mentioning PACB.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…